In its legislated mandate as a national leader and advisor on substance abuse policy, CCSA is often called upon to present research findings and provide evidence-informed analysis on substance abuse issues to government.
The following links represent recent presentations and speeches CCSA senior staff and research and policy analysts have been invited to make before special Parliamentary Committees.
CCSA CEO Michel Perron presents to delegates at the 51st Regular Session of the Inter-American Drug Abuse Control Commission (CICAD) on the role of NGOs in enhancing drug policy-making. View the presentation. (May 11, 2012)
Drug Policy in the United States (November 22, 2010)
A presentation by Director R.Gil Kerlikowski, White House Office of National Drug Control Policy (ONDCP), hosted by the Canadian Centre on Substance Abuse (speaking notes as prepared)
Bill C-15 Briefing to the Senate Standing Committee on Legal and Constitutional Affairs (November 26, 2009)
Michel Perron, CEO, Canadian Centre on Substance Abuse (CCSA)
Presentation to the House of Commons Standing Committee on Justice and Human Rights (February 28, 2008)
Doug Beirness, Manager, Research and Policy, Canadian Centre on Substance Abuse (CCSA)
Presentation to the Senate Committee on Legal and Constitutional Affairs on Bill C-2 (February 25, 2008)
Doug Beirness, Manager, Research and Policy, Canadian Centre on Substance Abuse (CCSA)
Presentation to the Standing Committee on Justice and Human Rights on Bill C-428, An Act to amend the Controlled Drugs and Substances Act (methamphetamine) (December 13, 2007)
Rebecca Jesseman, Policy Analyst, Research and Policy, Canadian Centre on Substance Abuse (CCSA)
Presentation to the Standing Committee on Justice and Human Rights on Bill C-32 [an Act to amend the Criminal Code (impaired driving) and to make consequential amendments to other Acts] (June 12, 2007)
Doug Beirness, Manager, Research and Policy, Canadian Centre on Substance Abuse (CCSA)
Drug Policy in the United States (February 22, 2007)
A presentation by Director John P. Walters, White House Office of National Drug Control Policy (ONDCP), hosted by the Canadian Centre on Substance Abuse (CCSA). (Official event transcript)
Note: The ONDCP has provided written responses to participant's questions that could not be addressed in the Q&A session, due to time restrictions. Click here to access the document.
Alcohol and Drugs in Canada: Current Knowledge - Future Implications (October 17, 2006)
CCSA Board of Directors, Breakfast Briefing on the Hill
Presentation to the Standing Senate Committee on Social Affairs, Science, and Technology: Mental Health, Mental Illness and Addiction (September 21, 2005)
Michel Perron, CEO, Canadian Centre on Substance Abuse (CCSA)
Presentation to the Standing Committee on Justice, Human Rights, Public Safety and Emergency Preparedness on Bill C-16 [an Act to amend the Criminal Code (impaired driving) and to make consequential amendments to other Acts] (June 23, 2005)
Patricia Begin, Director, Research and Policy, Canadian Centre on Substance Abuse (CCSA)
Presentation to the Standing Committee on Health on Bill C-206, an Act to Amend the Food and Drugs Act (March 21, 2005)
Michel Perron, CEO, Canadian Centre on Substance Abuse (CCSA)